familymednews.com
A new study by University of Manitoba, CancerCare Manitoba and Mayo Clinic researchers has found that when women at high risk are provided with the results of genetic testing, they are more likely to take preventive medications to reduce their chances of developing breast cancer. Studies have shown that the risk of breast cancer can be reduced by half using […]
Continue reading »
A global survey of HER2 testing has raised questions about how resources should be spent on potentially lifesaving HER2 targeted therapies for breast cancer, especially in poorer countries. The results were presented at the ESMO Breast Cancer Congress 2019, Berlin, 2-4 May 2019. The ONCOLLEGE-001 internet-based survey of HER2 testing in 45 countries has highlighted major access and affordability issues […]
Continue reading »
About one in eight women in the United States will develop breast cancer in their lifetime. The vast majority of these cancers rely on the hormone estrogen to grow. Estrogen-receptor positive (ER+) breast cancer tumors are frequently treated with the drug tamoxifen, which blocks the hormone’s effect on the tumor. However, many tumors eventually become resistant to tamoxifen, allowing cancer […]
Continue reading »
Maintaining a healthy weight and not consuming alcohol regularly could help prevent thousands of breast cancer cases, a new big data study by UNSW Sydney researchers has found. The findings could help inform future cancer control strategies. The large collaborative study led by UNSW’s Centre for Big Data Research in Health was published in the International Journal of Cancer. It […]
Continue reading »
Researchers at Kanazawa University report in Proceedings of the National Academy of Sciences (PNAS) that a particular signaling pathway in breast cancer tumors causes cancer cells to divide symmetrically, expanding the tumor. Inhibiting the pathway with drugs could become a strategy for eliminating the cancer cells. In breast cancer, one of the most common cancers in women, tumors contain a […]
Continue reading »
Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change. A Vanderbilt team led by John Wilson, assistant professor of chemical and biomolecular engineering, and Rebecca Cook, associate professor of cell and developmental biology, activated innate immunity in breast cancer cells and […]
Continue reading »
A study by researchers at University of Colorado Cancer Center and Oregon Health & Science University published today in the Journal of the American Medical Association Network shows that breast cancers diagnosed in young women within 10 years of giving birth are more likely to metastasize, and thus more likely to cause death, than breast cancers in young women who […]
Continue reading »
It is encouraging to see greater attention in the media to the issue of climate change and its effects on the life-support systems of the planet. The link between breast cancer and the environment, however, is being overlooked. Premenopausal women exposed to high levels of air pollution have a 30 per cent increased risk for breast cancer, according to a […]
Continue reading »
In American women, breast cancer is the most common cancer and the second-leading cause of cancer death. While routine screening helps to detect breast cancer, existing technology frequently identifies suspicious lesions that turn out not to be cancer. In fact, up to 80 percent of the biopsies performed reveal the suspicious areas are not cancerous. A team of scientists at […]
Continue reading »
Poor diet and lack of exercise are associated with cancer development, but the underlying biology is not well understood. Advanced glycation end products (AGEs) could offer a biological link to help us understand how certain lifestyle behaviors increase cancer risk or lessen the likelihood that an anti-cancer therapy will be effective. AGE accumulation is the natural and unavoidable result of […]
Continue reading »